97 related articles for article (PubMed ID: 31197213)
1. Vascular tortuosity of the internal carotid artery is related to the RNF213 c.14429G > A variant in moyamoya disease.
An S; Kim T; Oh CW; Bang JS; Lee SU; Heo J
Sci Rep; 2019 Jun; 9(1):8614. PubMed ID: 31197213
[TBL] [Abstract][Full Text] [Related]
2. Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213.
Li F; Huang YY; Zhang S; Wang W
Br J Neurosurg; 2023 Dec; 37(6):1882-1885. PubMed ID: 35642380
[TBL] [Abstract][Full Text] [Related]
3. RNF213-Related Vasculopathy: Various Systemic Vascular Diseases Involving RNF213 Gene Mutations: Review.
Murai Y; Matano F; Kubota A; Nounaka Y; Ishisaka E; Shirokane K; Koketsu K; Nakae R; Tamaki T
J Nippon Med Sch; 2024; 91(2):140-145. PubMed ID: 38777780
[TBL] [Abstract][Full Text] [Related]
4. Impact of RNF213 c.14576G>A Variant on the Development of Direct and Indirect Revascularization in Pediatric Moyamoya Disease.
Kawabori M; Ito M; Kazumata K; Tokairin K; Hatanaka KC; Ishikawa S; Houkin K; Fujimura M
Cerebrovasc Dis; 2023; 52(2):171-176. PubMed ID: 36063804
[TBL] [Abstract][Full Text] [Related]
5. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
Elife; 2020 Jun; 9():. PubMed ID: 32573437
[TBL] [Abstract][Full Text] [Related]
6. Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells.
Li Z; Liu Y; Li X; Yang S; Feng S; Li G; Jin F; Nie S
Neurosurg Rev; 2024 May; 47(1):246. PubMed ID: 38811382
[TBL] [Abstract][Full Text] [Related]
7. Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan study: PCA involvement in unilateral moyamoya.
Mineharu Y; Takagi Y; Koizumi A; Morimoto T; Funaki T; Hishikawa T; Araki Y; Hasegawa H; Takahashi JC; Kuroda S; Houkin K; Miyamoto S;
J Stroke Cerebrovasc Dis; 2024 Feb; 33(2):107513. PubMed ID: 38141320
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population.
Chen J; Zheng H; Wu X; Niu X; Dai Y; Zhou Z; Ye F
J Stroke Cerebrovasc Dis; 2024 Mar; 33(3):107581. PubMed ID: 38224792
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya Vasculopathy and Moyamoya-Related Systemic Vasculopathy: A Review With Histopathological and Genetic Viewpoints.
Abumiya T; Fujimura M
Stroke; 2024 Jun; 55(6):1699-1706. PubMed ID: 38690664
[TBL] [Abstract][Full Text] [Related]
10. Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: possible involvement of intrinsic vascular vulnerability.
Uchino H; Ito M; Tokairin K; Tatezawa R; Sugiyama T; Kazumata K; Fujimura M
Neurosurg Rev; 2023 May; 46(1):119. PubMed ID: 37166684
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and intracranial arterial lesions of non-young adult ischemic stroke patients with RNF213 p.R4810K variant.
Ogura S; Ohara T; Tanaka E; Ashida S; Maezono-Kandori K; Hanya M; Mizuta I; Mizuno T
J Neurol Sci; 2023 Sep; 452():120775. PubMed ID: 37657303
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease.
Thamamongood T; Hara S; Akagawa H; Inaji M; Tanaka Y; Nariai T; Maehara T
Neurol Med Chir (Tokyo); 2024 Jan; 64(1):43-49. PubMed ID: 38057092
[TBL] [Abstract][Full Text] [Related]
13. RNF213 vasculopathy manifested in various forms within a family: A case report.
Lim SS; Park S; Oh BH; Jung K; Bae JW; Bae DH
Medicine (Baltimore); 2023 Dec; 102(50):e36627. PubMed ID: 38115307
[TBL] [Abstract][Full Text] [Related]
14. Aplastic or twig-like middle cerebral artery and cardiogenic cerebral embolism mimicking moyamoya disease with RNF213 polymorphism: A case report.
Inoue H; Oomura M; Nishikawa Y; Mase M; Matsukawa N
Interv Neuroradiol; 2022 Dec; 28(6):634-638. PubMed ID: 34913393
[TBL] [Abstract][Full Text] [Related]
15. RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway.
Ye F; Niu X; Liang F; Dai Y; Liang J; Li J; Wu X; Zheng H; Qi T; Sheng W
Brain; 2023 Nov; 146(11):4674-4689. PubMed ID: 37399508
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of Rnf 213 gene contributes to T cell response via antigen uptake, processing, and presentation.
Tashiro R; Niizuma K; Kasamatsu J; Okuyama Y; Rashad S; Kikuchi A; Fujimura M; Kure S; Ishii N; Tominaga T
J Cell Physiol; 2021 Nov; 236(11):7554-7564. PubMed ID: 33973242
[TBL] [Abstract][Full Text] [Related]
17. Arg4810Lys mutation in RNF213 among Eastern Indian non-MMD ischemic stroke patients: a genotype-phenotype correlation.
Sadhukhan D; Mitra P; Mishra S; Roy A; Podder G; Ray BK; Biswas A; Hui SP; Banerjee TK; Biswas A
Neurol Sci; 2024 Jan; 45(1):315-319. PubMed ID: 37698787
[TBL] [Abstract][Full Text] [Related]
18. A Noonan-like pediatric patient with a de novo CBL pathogenic variant and an RNF213 polymorphism p.R4810K presenting with cardiopulmonary arrest due to left main coronary artery ostial atresia.
Chida-Nagai A; Tonoki H; Makita N; Ishiyama H; Ihara M; Maruo Y; Tsujioka T; Sasaki D; Izumi G; Yamazawa H; Kato N; Ito M; Fujimura M; Sasaki O; Takeda A
Am J Med Genet A; 2023 Dec; 191(12):2837-2842. PubMed ID: 37554039
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study identifies novel susceptibilities to adult moyamoya disease.
Jeon JP; Hong EP; Ha EJ; Kim BJ; Youn DH; Lee S; Lee HC; Kim KM; Lee SH; Cho WS; Kang HS; Kim JE
J Hum Genet; 2023 Oct; 68(10):713-720. PubMed ID: 37365321
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Massive Cerebral Infarction in Pediatric Patients With Moyamoya Disease.
Hao F; Gao G; Guo Q; Liu S; Wang M; Chang Z; Wang H; Lu M; Liu S; Zou Z; Zhang Q; Wang X; Fu H; Li J; Han C; Duan L
Pediatr Neurol; 2024 Apr; 153():159-165. PubMed ID: 38394830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
